Home › Funds › Spruce Street Capital LP › RLMD

Spruce Street Capital LP position in RLMD

RELMADA THERAPEUTICS INC · Health Care

Spruce Street Capital LP reported holding 6,912,191 shares of RLMD (RELMADA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$26.1M, representing 4.14% of its reported portfolio and ranking #10 among its reported holdings. Spruce Street Capital LP has disclosed RLMD holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)6.91M sh
Reported value held$26.06M
Portfolio Weight4.14%
First reportedQ4 2025
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Spruce Street Capital LP's RLMD position evolved

Spruce Street Capital LP first disclosed a stake in RLMD in Q4 2025 at 4,086,181 shares (US$19.7M). The position peaked in Q2 2026 at 6,391,328 shares, worth US$44.2M. Across 4 filings, Spruce Street Capital LP increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 6,912,191 shares valued at US$26.1M — an increase of 520,863 shares quarter over quarter.. Notable position changes include a 53% increase in Q1 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 4.09M $19.74M New
Q1 2026 6.26M $43.00M Add
Q2 2026 6.39M $44.23M Add
Q3 2026 6.91M $26.06M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RLMD and 13F data

RLMD (RELMADA THERAPEUTICS INC) is a Health Care company. 70 other funds we track also report a position in RLMD — the largest reported positions include Squadron Capital Management LLC (US$50.9M), Venrock Adviser, LLC (US$47.4M), Jones Hill Capital LP (US$19.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RLMD

All RLMD fund holders →

FAQ

How long has Spruce Street Capital LP held RLMD?

Spruce Street Capital LP has disclosed RLMD holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Spruce Street Capital LP's current position in RLMD?

As of Q3 2026, Spruce Street Capital LP holds 6.91M shares of RLMD (RELMADA THERAPEUTICS INC), valued at $26.06M, representing 4.14% of its reported portfolio and ranking #10.

Has Spruce Street Capital LP been buying or selling RLMD?

In the latest 13F filing (Q3 2026), Spruce Street Capital LP increased its position in RLMD. The position peaked in Q2 2026 at 6.39M shares.

Which other funds hold RLMD?

Other major institutional holders of RLMD include Squadron Capital Management LLC, Venrock Adviser, LLC, Jones Hill Capital LP, among 70 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.